Sort   by:  
 Page size 
UnknownDisruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.
Not available
S-EPMC3548957 | biostudies-literature
UnknownImmunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
Not available
S-EPMC3020702 | biostudies-literature
UnknownMutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression.
Not available
S-EPMC5415422 | biostudies-literature
UnknownPhase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
Not available
S-EPMC2667825 | biostudies-literature
UnknownCancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.
Not available
S-EPMC6034685 | biostudies-literature
UnknownAdaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities.
Not available
S-EPMC5754242 | biostudies-literature
UnknownIntratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils.
Not available
S-EPMC10124325 | biostudies-literature
UnknownNovel role of hematopoietic stem cells in immunologic rejection of malignant gliomas.
Not available
S-EPMC4404923 | biostudies-literature
UnknownApplication of mutagen sensitivity assay in a glioma case-control study.
Not available
S-EPMC5977159 | biostudies-literature
UnknownRecurrent Glioblastoma Treated with Recombinant Poliovirus.
Not available
S-EPMC6065102 | biostudies-literature
Sort   by:  
 Page size